SEMAGRIX 0.25MG INJECTION

💉 Semagrix Injection 0.25 mg / 0.5 mg / 1 mg (Semaglutide)

🩺 Description
Semagrix contains semaglutide, a GLP-1 receptor agonist used to improve blood sugar control in adults with type 2 diabetes. In some countries and formulations, semaglutide is also prescribed for chronic weight management in people with obesity or overweight who meet specific medical criteria. It is given as a once-weekly subcutaneous (under-the-skin) injection.

⭐ Key Benefits

• 🩸 Helps lower blood sugar (HbA1c)
• ⚖️ Supports weight loss when prescribed with diet and exercise
• ❤️ May reduce the risk of major cardiovascular events in eligible patients with type 2 diabetes
• 📅 Convenient once-weekly dosing
• 🍽️ Helps reduce appetite and slows stomach emptying

💉 Dosage

• ✅ 0.25 mg once weekly for the first 4 weeks (starting dose)
• ✅ Increase to 0.5 mg once weekly after 4 weeks
• ✅ If additional blood sugar control is needed, increase to 1 mg once weekly after at least 4 weeks on 0.5 mg, as directed by your doctor
• Inject under the skin of the abdomen, thigh, or upper arm on the same day each week.

📋 Uses

• ✅ Treatment of Type 2 Diabetes Mellitus
• ✅ Weight management (when prescribed for eligible adults)
• ✅ Reduction of cardiovascular risk in certain adults with type 2 diabetes and established cardiovascular disease

⚠️ Common Side Effects

• 🤢 Nausea
• 🤮 Vomiting
• 💩 Diarrhea or constipation
• 🤕 Headache
• 😣 Stomach pain or indigestion
• 🍽️ Decreased appetite

Note: Semagrix is a prescription-only medicine. It should not be used in type 1 diabetes or diabetic ketoacidosis. Patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) should not use semaglutide unless specifically advised by their healthcare provider.